compounding glp 1 ban Compounded GLP-1 ban: What providers need to know Novo Nordisk calls out dangers

Injectable medications ensure controlled hormone delivery, while patches rely on unproven transdermal methods that poorly transport hormone-based compounds

GLP-1s interfere with hunger signals, so skipping meals due to not feeling hungry can backfire

I haven't seen convincing evidence that any of these will make a significant impact on weight loss." My Verdict: Another expensive disappointment

The research is genuinely compelling

Per the FDA meeting notice, the agency reviewed each peptide for a narrow use: BPC-157 for ulcerative colitis, KPV for wound healing and inflammatory conditions, TB-500 for wound healing, and MOTS-c for obesity and osteoporosis